Ignite Creation Date:
2025-12-25 @ 4:55 AM
Ignite Modification Date:
2026-06-27 @ 2:15 AM
Study NCT ID:
NCT06745518
Status:
COMPLETED
Last Update Posted:
2025-08-07
First Post:
2024-12-17
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Phase 2 Study of TS-172 in Hyperphosphatemia Patients on Hemodialysis With Phosphate Binders
Sponsor:
Taisho Pharmaceutical Co., Ltd.
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
TS172-02-03
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None